Covetrus® (NASDAQ: CVET), a global leader in animal-health technology and services, today announced that it has completed the sale of its scil animal care business (“scil”) to Heska Corporation (“Heska”) (NASDAQ: HSKA). The transaction closed under an amended purchase agreement which reduced the total consideration paid to Covetrus from $125 million to $110 million. In conjunction with the price adjustment, an approximate $10 million escrow fund that was to be funded by Heska and used as collateral for a period of up to 18 months for any potential claims tied to the transaction was eliminated.
Read the full article: Covetrus Completes Sale of scil animal care to Heska //
Source: https://www.businesswire.com/news/home/20200401005400/en/Covetrus-Completes-Sale-scil-animal-care-Heska